Joltoo
InvestorsInsights
DeepTech 2026 Playbook
Browse all
  1. Home
  2. /Investors
  3. /Biotech
  4. /Foresite Capital
Foresite Capital

Foresite Capital

DeepTech NativeSan Francisco, United StatesActiveWebsiteLinkedIn
Stage FocusSeed, Series A, Series B+
GeographyUS
TypeVC
Last Activity2025
Industry Focus
Industries
BiotechMedTechAI Infrastructure
Technical BenchStrong
Investor TypeDeepTech Specialist
ExposureMostly DeepTech Investments
Bio

Foresite Capital, founded in 2011 by Jim Tananbaum MD, manages $3.5B-plus—making it one of the largest dedicated healthcare and life sciences VCs. Fund VI closed at $900M in June 2024. Check sizes range from $2M to $75M, backing approximately 20 companies per fund through the full investment lifecycle.

The portfolio demonstrates deep tech conviction in genomics and precision medicine: 10x Genomic...

Notable Investments
1
10x Genomics
R
Relay Therapeutics
V
Vaxcyte
J
Juno Therapeutics
I
Intellia Therapeutics
P
Pacific Biosciences
Q
Quantum-SI

Similar Funds

ARTIS Ventures

ARTIS Ventures

San Francisco, United States

DeepTech NativeBiotechAI InfrastructureMedTechSeedSeries A
Osage University Partners

Osage University Partners

Bala Cynwyd, United States

DeepTech NativeBiotechMedTechClimate TechSeedSeries A
Section 32 (S32)

Section 32 (S32)

Palo Alto, United States

DeepTech NativeBiotechMedTechAI InfrastructureSeedSeries A
Abingworth

Abingworth

London, United Kingdom

DeepTech NativeBiotechMedTechSeedSeries A
Agent Capital

Agent Capital

Waltham, United States

DeepTech NativeBiotechMedTechNeurotechSeedSeries A
Bold Capital Partners

Bold Capital Partners

Santa Monica, United States

Pure DeepTechBiotechAI InfrastructureMedTechSeedSeries A
Joltoo
Privacy PolicyTerms of Service
© 2026 Joltoo. All rights reserved.